Drug abuse can be defined as the dependency, addiction, overuse of drugs such as opioids, nicotine, alcohol, cigarettes, and heroin, which are most commonly used by majority of population around the globe. There are several drugs such as Disulfiram, Acamprosate, Naltrexone, and Nicotine Replacement Therapy, which are used for treatment of addiction and dependency on these drugs.
Market Dynamics
Frequent product launches, approvals, and robust pipeline of novel products are expected to be the major driver for growth of the global drug abuse treatment market over forecast period. For instance, in April 2018, Lil' Drug Store Products Inc. launched its Nicotac brand nicotine gum in the market. Lil' Drug Store Products Inc. has launched its Nicotac in two nicotine strengths (2MG and 4MG nicotine polarcrilex). Furthermore, the increasing prevalence of drug abuse is expected to increase the demand for its treatment drugs which in turn is expected to fuel global drug abuse treatment market growth. For instance, according to the data published by World Health Organization (WHO) in 2018, around 7 million people die worldwide annually due to tobacco abuse.
Key features of the study:
- This report provides in-depth analysis of drug abuse treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global drug abuse treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., British American Tobacco plc. and others
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the drug abuse treatment market
Detailed Segmentation:
- Global Drug Abuse Treatment Market, By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- Global Drug Abuse Treatment Market, By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Buprenorphine
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- Global Drug Abuse Treatment Market, By Distribution Channel:
- Hospital
- Retail Pharmacies
- Online Pharmacies
- Global Drug Abuse Treatment Market, By Geography:
- North America Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Europe Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa Drug Abuse Treatment Market
- By Abuse Type :
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type:
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Nicotine Replacement Treatment
- Nicotine Patch
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Spray
- Nicotine Inhaler
- Non-Nicotine Medication
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Company Overview
- Product Portfolio
- Recent Developments
- Financial Performance
- Key Strategies
- Glenmark Pharmaceuticals
- Pfizer Inc.
- Mylan N.V.
- Odyssey Pharmaceuticals Inc.
- Lil' Drug Store Products Inc.
- Indivior Plc.
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- British American Tobacco plc.
“*” marked represents similar segmentation in other categories in the respective section.
